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ABSTRACT 
The aim for this study was to isolate the bioactive molecules, determine the biological activities and find the 
potential lead in Sonneratia caseolaris as antimicrobial drugs. Phytochemical examination on the methanol 
extract of the fruits gave about 37.37 g of crude and 4.82 % percentage yield which led to the isolation and 
characterization of compound I. This structure compound were elucidated and characterized by spectroscopic 
analysis by using IH and l3C Nuclear Magnetic Resonance (NMR) Spectroscopy, and Fourier Transform Infrared 
Spectroscopy (FTIR). In ligand-based pharmacophore modelling, the interaction of compound I with generated 
pharmacophore model shows the presence of hydrophobic (HY) and hydrogen bond acceptor (HBA) 
pharmacophore features with fit value of 35.4800. Biological evaluations were carried out on the methanol and 
hexane crude extracts. The results stated that the methanol crude extracts has higher LCso value that was 2344.0 
ppm. This higher value indicated that compound has no toxicity towards Artemia salina. In disc diffusion for 
antimicrobial test, it was found that Sonneratia caseolaris crude showed weak inhibition zone (7.33 mm and 7.00 
mm) towards Escherichia coli and mild inhibition towards Staphylococcus at/rells for both methanol and hexane 
crude. 
Keywords: Sonneralla caseolaris, antimicrobial, pharmacophore modelling, toxicity, biological evaluations 
ABSTRAK 
Tlljllan leajian ini adalall unlllk mengasingkan moleklll bioaklif, menentukan aktiviti biologi dan mencari potensi 
dalam Sonneratia caseolaris sebagai ubat anti-mikrob. Kajian fitokimia atas ekstrak metanol daripada bllah­
buahan memberilean lebih kllrang 37.37 g hasil peratllsan mentah dan 4.82 % yang membawa kepada 
pengasingan dan pencirian sebatian I. Sebatian struktllr telah dijelaskan dan ciri-ciri analisis spektroskopi 
dengan menggunakan 'H dan Be Nucle."Magnetic Resonance (NMR) Spektroskopi dan Fourier Transform 
Infrared Spektroslwpi (FTlR). Berdasarkan ligan pemodelan pharmacophore, interaksi sebatian I dengan model 
pharmacophore dijana mf!1IImjllkkan kehadiran hidrofobik (HY) dan ileatan hidrogen penerima ( HBA) ciri-ciri 
pharmacophore dengall nilai patllt 35.4800. Penilaian biologi telah dijalankan ke atas metanol dan ekstrak 
helcsana mentah. Keputllsan menyatalean bahawa ekstrak metanol mentah mempllnyai nilai LCJo yang paling 
tinggi iaitu sebanyak 2344.0 ppm. Nilai ini lebih tinggi menunjukkan bahawa sebatian tidak toksik terhadap 
Artemia salina. Dalam penyebaran cakera IInluk ujian antimikrob, didapati bahawa Sonneratia caseolaris 
mentah menllnjllklean zon perencatan rendah (7.33 mm dan 7.00 mm) ke arah Escherichia coli dan perencatan 
sederhana ke arah Staphylococcus aureus untuk kedlla-dua metanol dan heksana mentah. 
Kala kunci:Sonneralia caseolaris. antimicrobial. pemodelan pharmacophore, toksik. peniJaian biologi 
1.0 INTRODUCTION 

1.1 General introduction 
Computer-aided Drug Design (CADD) is a computational methods and resources that are used 
to facilitate the design and discovery of new therapeutic solutions (Song et a/., 2009). It shows 
that search for new potent antimicrobial drug is essential to provide a safer treatment for the 
patients. A pharmacopITore can be derived into two methods which are ligand-based and 
structure-based (Wobler et a/., 2008). However, it shows that there have been only a few 
studies on Sonneratia caseo/aris regarding the pharmacological activities and discovery of 
new drug by using CADD. Therefore, this is an opportunity to develop and search for new 
potent antimicrobial drug from the fruit of Sonneratia caseo/aris plant that could be 
commercialize. 
Sonneratia caseo/aris is one of typical mangrove tree species known as "kirala" that grows 
well in brackish water bodies in Sri Lanka (Abeywickrama & Jayasooriya, 2010) (Figure 1.1). 
In Malaysia, the fruit is known as "pedada" or "berembang". Sonneratia caseo/aris belongs to 
the family Sonneratiaceae (Nazli & Hashim, 2010). Howlader et a/., (2012) had states that 
Sonneratia caseo/aris species is wides~ad and can be found easily in Asia. Based on 
previous research, Sonneratia caseo/aris old fruit walls are used for helmintic infections, half­
ripe fruit for coughs, while the pounded leaves for hematuria and small pox (Rahmatullah et 
a/., 2012). In addition, studies state that the calyces of Sonneratia caseo/aris exhibited the 
strong antioxidant activity then followed by stamens (Bunyapraphatsara et a/., 2003). As for 
toxicity test, it shows that the leaf of Sonneratia caseo/aris methanolic was not toxic to 
A mia salina (Melki el a/., 2011). 
2 
Previous studies states that steroids, flavonoids , triterpenoids and benzene carboxylic 
derivatives have been isolated and identified from the stems and twigs of Sonneratia 
caseo/aris (Tian et al., 2009). It shows that this plant contains high potential secondary 
metabolites that have medicinal value. The value of these secondary metabolites is increasing 
due to the constant discoveries of their potential role in drug development (Remani et al., 
2012). Figure l.l shows the plant that was discovered in this study. 
Figure l~Sonneratia caseolaris plants 
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1.2 Objectives 
This study will cover the following objectives: 
1. 	 To extract and isolate the chemical compounds from fruits of S. caseolaris by using 
chromatography techniques. 
2. 	 To characterize and identify the chemical constituents by using Gas Chromatography­
Mass Spectrometry (GC-MS), Fourier Transform Infrared Spectroscopy (FTIR) and 
Nuclear Magnetic Resonance Spectroscopy (NMR). 
3. 	 To generate pharmacophore model by using commercial drugs. 
4. 	 To determine fit value of phytochemical constituents originate in S. caseolaris with 
commercial drugs by using the ligand-based pharmacophore modeling approach 
(LigandScout 3.1). 




2.0 LITERATURE REVIEW 

2.1 Computer-aided drug design (CAD D) 
Song et ai., (2009) states that Computer-aided drug design (CADD) is a specialized discipline 
that uses computational knowledge based methods to aid and facilitate the new drug discovery 
solutions. According to Kalyaanamoorthy & Chen, (2011) as for searching high affinity of 
flies repellent, a powerful molecular modelling technique has been useful in designing lead 
targets. To design good drugs, biological drug interactions should be considered such as using 
CADD to design a new drug of molecules in order to treat certain diseases in the human 
(McCarthy, 1999). The application of CADD was supported by using pharmacophore 
modelling. Chemical features based 3D pharmacophore models was built using computer 
software LigandScout 3.1 and used to evaluate and produced the geometrical structures of 
training set in their active forms (Figure 2.1). An established compound from Protein Data 
Bank (PDB) was used as training set. All structure of test set was generated and optimized 
using computer ChemDraw Ultra 12.0 software. Pharmacopore model were generated using a 
series of selected training set and then were mapped with test set. Figure 2.2 illustrated the 





Figure 2.1 LigandScout 3.1 software 
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Figure 2.2 The workflow ofpharmacophore modelling (Langer & Wolber, 2004) 
2.1.1 Pharmacophore modelling 
The phannacophore can be derived both in a structure-based methods which between a ligand 
and its binding site, or in a ligand-based methods, which flexibly overlaying a set of active 
molecules and detennining those conformations that are able to be overlapped in such a way 
that a maximum number of important "'emical features geometrically overlap (Wobler et at. , 
2(08). Phannacophore modeling approach is the technique rigidly models the interaction 
between a ligand and its binding site in a specific binding situation. The result is a three-
dimensional (3D) spatial arrangement of chemical features. These feature maps, called 3D 
phannacophores, can be used to search for similarities between binding situations or even for 
similarities between molecules. 
6 
Pharmacophore model 
Pbarmacophore align molecule based on the three dimensional (3D) arrangement of chemical 
features. Noureen et al., (2010), states that the generated pharmacophore hypothesis usually 
COD8ist of five specific features which are one negatively ionizable group (NI), two 
hydrophobic aromatic (HY), one hydrogen bond acceptor (HBA) and one hydrogen bond 
donor (HBD). 
Previous study on phannacophore shows that the approach utilized in the study is successful in 
finding three potent Ftase inhibitors from Indian Plant Anticancer Database. Individually those 
Ihree compounds are from group of vinca alkaloid & show lowest docked energy and 
hydrogen bonding stabilizes the interaction (Khan et ai., 2010). Besides, study shows that the 
discovery of ARRR.5 phannacophore model was created by using indolizine derivatives 
acting as IS-LOX inhibitors. The hypothesis ARRR.5 might be considered as the best 
pharmacophore model because it displayed a good regression coefficient value of 0.9451, 
Pearson R 0.7439 and survival score 3.094 (Sharma & Kumar, 2015). 
2.1.2 Structure-based drug design (SBDD) 
Structure-based drug design (SBDD)tia the one with computational method shows that it 
assists to enhance progress in discovery and refmement of therapeutic agents (Marrone et ai., 
1997). According to Kuntz, (1992) structure-based drug design refers to the complex process 
ofusing the information contained in the three-dimensional, 3D structure of a macromolecular 
target and related ligand-target complexes to design novel drugs for important human diseases. 
Structural information about a given macromolecular target will leads to a better 
7 
understanding of its specific function and enables the design of small molecule ligands that 

can bind to the target. 

Pbarmacophore modelling is one of the SBDD applications where it used training set (protein) 

fiom literature and database search (RCSB Protein Data Bank) to generate a pharmacophore 

model. This phannacophore modelling was carried out using LigandScout 3.1 software. 

2.1.3 Ligand-based drug design (LBDD) 
Ligand-based drug design is a method used in the absence of the receptor 3D information and 
it relies on knowledge of binding molecules to the biological target of interest. 3D quantitative 
sbucture activity relationships (3D QSAR) and pharmacophore modeling are the most 
important tools used in ligand-based drug design (Aparoy et a/., 2012). 
2.2 Sonneratia caseolaris 
S. caseo/aris is one of typical mangrove tree species known as "kirala" that grows well in 
brackish water bodies in Sri Lanka (Abeywickrama & Jayasooriya, 2010). In Malaysia, the 
fruit is known as "pedada", "berembang", crabapple mangrove or mangrove apple. S. 
CQSeo/aris belongs to the family Sonneratiaceae (Nazli & Hashim, 2010). S. caseo/aris species 
is widespread and can be found in Bangladesh, Brunei Darussalam, Cambodia, China, India, 
Indonesia, Malaysia, Myanmar, Philippines, Singapore, Sri Lanka, Thailand, Viet Nam, 
ortheast Australia, Papua New Guinea, Solomon Islands, Vanuatu, New Caledonia, and 
Maldives (Md. S I. Howlader el a/., 2012). Table 2.1 shows the taxonomy of the S. caseo/aris 
plants. 
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Table 2.1 Taxonomy ofSonneratia caseolaris 
Figure 2.3 The S. caseolaris fruit and leaves 
Ahmc:d et ai., (2010) has states that the mangrove tree has oblong or obovate-elliptic 
coriaceous leaves and large red flowers. The tree also can grow up to 15-20 meters high. This 
ical non-viviporous mangrove species have their own benefits such as the fruit is edible, 
is used as a skin cosmetic, and leaves are used for feeding goats (A venido & Serrano, 
12) (Figure 2.3). The ripened fruits of S. caseolaris have an appealing flavor and taste that 
be used to prepare a delicious fruit drink. The fruit also contains a large number of small 
9 
anbcdded in the fleshy part which are bitter if eaten (Abeywickrama & Jayasooriya, 
0). The tree flowers are edible as vegetable with nampriks (spicy dish). "Pedada" is a sour 
young berry fruits that are edible (Wetwitayaklung et al., 2013). In addition, the mature 
• n:aUy have a cheese like taste and can be eaten raw or cooked. Its stem and branch are 
for firewood, building boats, posts of bridges and houses. Other than that, it can absorb, 
1CCUIIlUlate, distribute and circulate that heavy metal such as Cu, Pb, Zn, Cr and Ni in 
DllllIIOiVe community (Wetwitayaklung et al., 2013). 
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PIaytocbemical constituents in Sonneratia caseolaris fruits 
1.3.1 Flavonoids 
FlavmlOids is one of secondary metabolites group which responsible for antioxidant activity. 
on previous studies, two flavonoids such as luteolin (Figure 2.4a) and luteolin-7 -O-~-
a1UlICOIlide (cynaroside) (Figure 2.4b) have been isolated from Sonneratia caseolaris leaves 








Figure 2.4 Example of flavonoid structures 
2.3.2 Sterols 
tcrola are also known as steroid alcohols which occur naturally in plants. Based on previous 
sterols compound have been id led from the stem and twigs of S. caseolaris. The 
Is that have been isolated are 6'-O-Acetyl-~-daucosteroJ, ~-Sitosterol (Figure 2.5a), 
Daucosterol (Figure 2.5c), P-Sitosterol palmitate (Figure 2.5d), Stigmast-5-en-3~-O-(6-0-
heudecanoyl-P-Dglucopyranoside, and Cholest-5-en-3~,7u-diol (Tian et al., 2009). After that, 
TlWIri el at., (2010) states that through extraction and isolation, bioactive compound from the 











ritc:rpenoids are one of the seconda ~etabolites that represent the largest group of 
phytochemicals and research shown that it can be found in various plants including fruits and 
medicinal herbs (Bishayee et al., 2011). Previous study shows that maslinic acid, betulin, 
Iupeol and oleanolic can be found in S. caseolaris plants (Figure 2.6). Besides, oleanolic acid 
ell known to possess anti-inflammatory, antihyperlipidemic and hepatoprotective activities 
and sold as oral drug for human liver disorder in China (Liu, 1995) (Figure 2.6d). 
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